4 Recruiting Myeloma Multiple Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Recruiting Myeloma Multiple Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure
📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase4 💊 Investigational Drug / Biologic
Bioequivalence Studies of Dasatinib 100 Mg
📍 CAIMED — Chía, Cundinamarca
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 📋 Clinical Research Protocol
Limited-duration Teclistamab
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔